Variables | Rheumatoid arthritis | IRR (95% CI) | Adjusted HR† (95% CI) | |||||
---|---|---|---|---|---|---|---|---|
No | Yes | |||||||
Event | PY | Rate‡ | Event | PY | Rate‡ | |||
DVT | 255 | 792 941 | 3.22 | 208 | 193 753 | 10.70 | 3.34 (3.22 to 3.46)*** | 3.36 (2.79 to 4.03)*** |
Sex | ||||||||
Female | 191 | 618 905 | 3.09 | 167 | 152 011 | 11.0 | 3.56 (3.41 to 3.71)*** | 3.58 (2.90 to 4.40)*** |
Male | 64 | 174 035 | 3.68 | 41 | 41 742 | 9.82 | 2.67 (2.47 to 2.89)*** | 2.74 (1.85 to 4.06)*** |
Stratified age | ||||||||
≤50 | 27 | 343 813 | 0.79 | 40 | 87 222 | 4.59 | 5.84 (5.48 to 6.22)*** | 5.55 (3.40 to 9.07)*** |
50–65 | 108 | 291 976 | 3.70 | 78 | 70 954 | 11.0 | 2.98 (2.80 to 3.16)*** | 2.83 (2.11 to 3.79)*** |
65+ | 120 | 157 152 | 7.64 | 90 | 35 577 | 25.3 | 3.31 (3.07 to 3.57)*** | 3.20 (2.43 to 4.21)*** |
Comorbidity§ | ||||||||
No | 173 | 714 076 | 0.24 | 143 | 167 162 | 0.86 | 3.53 (3.39 to 3.68)*** | 3.75 (3.00 to 4.68)*** |
Yes | 82 | 78 865 | 1.04 | 65 | 26 591 | 2.44 | 2.35 (2.14 to 2.59)*** | 2.41 (1.74 to 3.34)*** |
PE | 139 | 793 285 | 1.75 | 70 | 194 299 | 3.60 | 2.06 (1.97 to 2.14)*** | 2.07 (1.55 to 2.76)*** |
Sex | ||||||||
Female | 108 | 619 154 | 1.74 | 58 | 152 463 | 3.80 | 2.18 (2.08 to 2.28)*** | 2.20 (1.60 to 3.03)*** |
Male | 31 | 174 130 | 1.78 | 12 | 41 837 | 2.87 | 1.61 (1.47 to 1.77)*** | 1.61 (0.82 to 3.14) |
Stratified age | ||||||||
≤50 | 10 | 343 840 | 0.29 | 9 | 87 374 | 1.03 | 3.54 (3.32 to 3.78)*** | 3.13 (1.26 to 7.77)* |
50–65 | 47 | 292 117 | 1.61 | 26 | 71 165 | 3.65 | 2.27 (2.12 to 2.43)*** | 2.14 (1.32 to 3.46)** |
65+ | 82 | 157 328 | 5.21 | 35 | 35 761 | 9.79 | 1.88 (1.73 to 2.04)*** | 1.79 (1.20 to 2.66)** |
Comorbidity§ | ||||||||
No | 81 | 714 325 | 0.11 | 46 | 167 559 | 0.27 | 2.42 (2.32 to 2.53)*** | 2.58 (1.79 to 3.70)*** |
Yes | 58 | 78 960 | 0.73 | 24 | 26 740 | 0.90 | 1.22 (1.10 to 1.36)*** | 1.37 (0.85 to 2.21) |
*p<0.05, **p<0.01, ***p<0.001.
†Adjusted HR: multivariable analysis including age, sex and comorbidities.
‡Rate, incidence rate, per 10 000 person-years.
§Comorbidity: Patients with any one of comorbidities were classified as the comorbidity group.
DVT, deep vein thrombosis; IRR, incidence rate ratio; PE, pulmonary embolism.